News
Exemestane Prevents 65% of Invasive Breast Cancers in Postmenopausal Women
- Author:
- Jane Salodof MacNeil
Major Finding: The annual incidence of invasive breast cancer was 0.19% with exemestane vs. 0.55% with placebo (hazard ratio 0.35, P = .002).Data...
News
Exemestane Prevented Breast Cancers in Postmenopausal Women
- Author:
- Jane Salodof MacNeil
Major Finding: The annual incidence of invasive breast cancer was 0.19% with exemestane vs. 0.55% with placebo (hazard ratio 0.35, P = .002).Data...
News
Higher Methotrexate Dose Fends Off Pediatric Leukemia Recurrence
- Author:
- Jane Salodof MacNeil
Major Finding: Event-free survival at 5 years was 82% in the high-dose methotrexate arm and 75% with a standard Capizzi regimen (P=.006).Data...
News
Higher Methotrexate Dose Fends Off Pediatric Leukemia Recurrence
- Author:
- Jane Salodof MacNeil
Major Finding: Event-free survival at 5 years was 82% in the high-dose methotrexate arm and 75% with a standard Capizzi regimen (P=.006).Data...
News
Higher Methotrexate Dose Fends Off Pediatric Leukemia Recurrence
- Author:
- Jane Salodof MacNeil
Major Finding: Event-free survival at 5 years was 82% in the high-dose methotrexate arm and 75% with a standard Capizzi regimen (P=.006).Data...
News
FDA Approves Abiraterone for Castration-Resistant Prostate Cancer
- Author:
- Jane Salodof MacNeil
News
FDA Approves Abiraterone for Castration-Resistant Prostate Cancer
- Author:
- Jane Salodof MacNeil
News
Rituximab Maintenance Approved in Follicular Lymphoma
- Author:
- Jane Salodof MacNeil
News
Rituximab Maintenance Approved in Follicular Lymphoma
- Author:
- Jane Salodof MacNeil
News
Rituximab Maintenance Approved in Follicular Lymphoma
- Author:
- Jane Salodof MacNeil
News
Treatment-Related Death Toll Casts Doubt on "Auto-Allo" Transplants in Myeloma
- Author:
- Jane Salodof MacNeil
Major Finding: Progression-free survival rates at 3 years were similar at 46% in standard-risk multiple myeloma patients receiving tandem...
News
Novel Bosutinib Shows Mixed Results in Frontline CML
- Author:
- Jane Salodof MacNeil
Major Finding: At 12 months, the major molecular response rate reached 39% with bosutinib, compared with 26% with imatinib (P = .002), but the...
News
Double Cord Blood Transplant Better Than Single in Acute Leukemia
- Author:
- Jane Salodof MacNeil
Major Finding: Transplants of two units of cord blood pushed the 2-year leukemia-free survival rate to 53% vs.
News
FLVCR Function New Target in Fight Against Malaria
- Author:
- Jane Salodof MacNeil
News
FLVCR Function New Target in Fight Against Malaria
- Author:
- Jane Salodof MacNeil